- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Lung Therapeutics Inc.
Headquarters: Austin, TX, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | Oct 8, 2024
Management Tracks
Veteran investor Oleg Nodelman joins Galapagos board
Plus: New CEOs at QuantX, Oak Hill, and updates from Every Cure, Mosaic, Anixa and more
BioCentury | Jul 13, 2021
Management Tracks
Berkley joins AbCellera as CBO; plus Genespire, Corcept, Shoreline and more
Antibody discovery company AbCellera Biologics Inc. (NASDAQ:ABCL) hired Neil Berkley as CBO. Berkley joins from Halozyme Therapeutics Inc. (NASDAQ:HALO) where he was VP, head of business
BioCentury | Apr 14, 2021
Management Tracks
Management shuffle at Novavax; plus Skyhawk, Kyverna, Gemini and more
Greg Covino will step down as CFO and become executive adviser to Novavax Inc. (NASDAQ:NVAX). The vaccine developer hired Troy Morgan as SVP and chief compliance officer and promoted Gale Smith to SVP
BioCentury | Jun 4, 2019
Financial News
June 4 Financial Quick Takes: Lung Therapeutics' $36M series C; plus Strand, Hansoh, Inhibrx and more
BioCentury | Apr 13, 2018
Targets & Mechanisms
Meeting the burden
New developments in TMB, synthetic lethality, oncolytic viruses & more at AACR18
Items per page:
1 - 10 of 13